Home/Filings/4/0001104659-23-099685
4//SEC Filing

Pla Frederic 4

Accession 0001104659-23-099685

CIK 0001711933other

Filed

Sep 10, 8:00 PM ET

Accepted

Sep 11, 4:00 PM ET

Size

7.5 KB

Accession

0001104659-23-099685

Insider Transaction Report

Form 4
Period: 2023-09-07
Pla Frederic
Chief Operating Officer
Transactions
  • Purchase

    Common Stock

    2023-09-07$4.60/sh+13,000$59,81413,000 total(indirect: By Trust)
  • Purchase

    Common Stock

    2023-09-07$4.60/sh+7,000$32,20020,000 total(indirect: By Trust)
Holdings
  • Common Stock

    40,555
Footnotes (1)
  • [F1]The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions with prices ranging from $4.595 to $4.61 for a weighted average sale price of $4.6011. The reporting person undertakes to provide the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

Issuer

Akoya Biosciences, Inc.

CIK 0001711933

Entity typeother

Related Parties

1
  • filerCIK 0001649167

Filing Metadata

Form type
4
Filed
Sep 10, 8:00 PM ET
Accepted
Sep 11, 4:00 PM ET
Size
7.5 KB